<--- Back to Details
First PageDocument Content
Organofluorides / Selective serotonin reuptake inhibitors / Stereochemistry / Intellectual property law / Escitalopram / Supplementary protection certificate / Citalopram / Enantiomer / Lundbeck / Chemistry / Organic chemistry / Nitriles
Date: 2011-04-12 10:37:08
Organofluorides
Selective serotonin reuptake inhibitors
Stereochemistry
Intellectual property law
Escitalopram
Supplementary protection certificate
Citalopram
Enantiomer
Lundbeck
Chemistry
Organic chemistry
Nitriles

Add to Reading List

Source URL: www.eplawpatentblog.com

Download Document from Source Website

File Size: 106,23 KB

Share Document on Facebook

Similar Documents

Medical research / Clinical research / Health / Multi-speed Europe / Clinical data management / EudraCT / Clinical pharmacology / European Economic Area / Clinical Trials Directive / Clinical trial / Supplementary protection certificate

Trial results: Modalities and timing of posting VersionAprilInterventional Clinical Trials that ended on or after 21 Julyi.e. the date of finalisation of the programming according to Commission Gui

DocID: 1r4sk - View Document

Pharmaceuticals policy / Health / Pharmaceutical industry / Pharmacology / European Medicines Agency / European Union / Marketing authorization / European Directorate for the Quality of Medicines / EudraLex / European Pharmacopoeia / Orphan drug / Supplementary protection certificate

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

DocID: 1qVx6 - View Document

Law / Government / Foreign relations / Patent law / United States patent law / Compulsory license / Patent application / Patent / European Patent Convention / Unitary patent / Supplementary protection certificate / Term of patent in the United States

Question Q202 National Group: Sweden Suède Schweden Title:

DocID: 1qeRN - View Document

Pharmaceuticals policy / Pharmaceutical industry / Council of Europe / European Directorate for the Quality of Medicines / Marketing authorization / Bioequivalence / Test data exclusivity / European Medicines Agency / Supplementary protection certificate

B.12 AF user guide consolidated vet version EMA

DocID: 1pz2w - View Document

Clinical research / Pharmaceutical industry / Clinical data management / Drug safety / Electronic common technical document / Supplementary protection certificate / European Medicines Agency / Summary of Product Characteristics / Pharmacovigilance / Validation / Drug Master File

DOC Document

DocID: 1oZjJ - View Document